Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Ridker, N. Cook (2013)
Statins: new American guidelines for prevention of cardiovascular diseaseThe Lancet, 382
Rae-Ellen Kavey, D. Simons-Morton, Janet Jesus (2011)
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary ReportPediatrics, 128
Brian Kit, M. Carroll, D. Lacher, P. Sorlie, Janet DeJesus, Cyntjl Ogden (2012)
Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010.JAMA, 308 6
M. Pencina, A. Navar-Boggan, R. D'Agostino, K. Williams, Benjamin Neely, A. Sniderman, E. Peterson (2014)
Application of new cholesterol guidelines to a population-based sample.The New England journal of medicine, 370 15
C. Johnson, R. Paulose‐Ram, C. Ogden, M. Carroll, D. Kruszon-Moran, Sylvia Dohrmann, L. Curtin (2013)
National health and nutrition examination survey: analytic guidelines, 1999-2010.Vital and health statistics. Series 2, Data evaluation and methods research, 161
Michael Holmes, F. Asselbergs, Tom Palmer, F. Drenos, M. Lanktree, Christopher Nelson, C. Dale, S. Padmanabhan, Chris Finan, D. Swerdlow, V. Tragante, Erik Iperen, S. Sivapalaratnam, Sonia Shah, C. Elbers, T. Shah, J. Engmann, C. Giambartolomei, Jon White, D. Zabaneh, R. Sofat, S. McLachlan, Pieter Doevendans, A. Balmforth, A. Hall, K. North, B. Almoguera, R. Hoogeveen, Mary Cushman, M. Fornage, Sanjay Patel, S. Redline, D. Siscovick, Michael Tsai, Konrad Karczewski, M. Hofker, W. Verschuren, M. Bots, Y. Schouw, O. Melander, A. Dominiczak, RichardJ. Morris, Y. Ben-Shlomo, Jackie Price, M. Kumari, J. Baumert, Annette Peters, B. Thorand, Wolfgang Koenig, Tom Gaunt, Steve Humphries, R. Clarke, Hugh Watkins, M. Farrall, James Wilson, S. Rich, P. Bakker, Leslie Lange, G. Smith, Alexander Reiner, Philippa Talmud, Mika Kivimäki, Deborah Lawlor, F. Dudbridge, N. Samani, B. Keating, A. Hingorani, J. Casas (2014)
Mendelian randomization of blood lipids for coronary heart diseaseEuropean Heart Journal, 36
J. Graham, Allison Olchowski, T. Gilreath (2007)
How Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation TheoryPrevention Science, 8
S. Grundy, D. Becker, L. Clark, R. Cooper, M. Denke, James Howard, D. Hunninghake, D. Illingworth, R. Luepker, P. Mcbride, J. Mckenney, R. Pasternak, N. Stone, L. Horn, H. Brewer, J. Cleeman, N. Ernst, D. Gordon, D. Levy, B. Rifkind, J. Rossouw, P. Savage, S. Haffner, D. Orloff, M. Proschan, J. Schwartz, C. Sempos, Susan Shero, Elaine Murray, Susan Keller, Angela Jehle, T. Ganiats, Gary Graham (2015)
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
M. Barry, S. Edgman-Levitan (2012)
Shared decision making--pinnacle of patient-centered care.The New England journal of medicine, 366 9
M. Gillman, S. Daniels (2012)
Is universal pediatric lipid screening justified?JAMA, 307 3
W. Taylor, N. Unwin (2009)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
B. McCrindle, P. Tyrrell, R. Kavey (2013)
Will Obesity Increase the Proportion of Children and Adolescents Recommended for a Statin?Circulation, 128
J. Spence (2013)
Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
F. Taylor, Mark Huffman, S. Ebrahim (2013)
Statin therapy for primary prevention of cardiovascular disease.JAMA, 310 22
M. McGrady, K. Hommel (2013)
Medication Adherence and Health Care Utilization in Pediatric Chronic Illness: A Systematic ReviewPediatrics, 132
N. Stone, Jennifer Robinson, A. Lichtenstein, C. Noel, B. Merz, D. Lloyd‐Jones, C. Blum, P. Mcbride, R. Eckel, F. Schwartz, A. Goldberg, Susan Shero, Rn, D. Gordon, Sidney Smith, D. Levy, K. Watson, P. Wilson, Karen Eddleman, N. Jarrett, K. Labresh, Lev Nevo, J. Wnek, Jeffrey Anderson, J. Halperin, N. Albert, J. Hochman, B. Bozkurt, R. Kovacs, R. Brindis, Macc Ohman, L. Curtis, S. Pressler, D. DeMets, F. Sellke, R. Guyton, W. Shen, G. Tomaselli, Stone Nj, Robinson J, Lichtenstein Ah, M. Bairey, Blum Cn, Eckel Cb, Goldberg Rh, Gordon Ac, Levy D, Lloyd-Jones Dm, P. Mcbride, Js Schwartz, Shero St, Smith Sc, W. Wilson (2014)
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation, 129 25 Suppl 2
E. Amsterdam, N. Wenger, R. Brindis, D. Casey, T. Ganiats, D. Holmes, A. Jaffe, H. Jneid, R. Kelly, M. Kontos, G. Levine, P. Liebson, D. Mukherjee, E. Peterson, M. Sabatine, R. Smalling, Susan Zieman (2014)
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 64 24
B. Doran, Yu Guo, Jinfeng Xu, Howard Weintraub, S. Mora, D. Maron, S. Bangalore (2014)
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)Circulation, 130
Samuel Vinci, S. Rifas-Shiman, Jennifer Cheng, R. Mannix, M. Gillman, S. Ferranti (2014)
Cholesterol testing among children and adolescents during health visits.JAMA, 311 17
ImportanceHealth care practitioners who care for adolescents transitioning to adulthood often face incongruent recommendations from pediatric and adult guidelines for treatment of lipid levels. ObjectiveTo compare the proportion of young people aged 17 to 21 years who meet criteria for pharmacologic treatment of elevated low-density lipoprotein cholesterol (LDL-C) levels under pediatric vs adult guidelines. Design, Setting, and ParticipantsWe performed a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) population. Surveys were administered from January 1, 1999, through December 31, 2012, and the analysis was performed from June through December 2014. Participants included 6338 individuals aged 17 to 21 years in the United States. Main Outcomes and MeasuresTo estimate the number and proportion of individuals aged 17 to 21 years in the NHANES population who were eligible for statin therapy, we applied treatment algorithms from the 2011 Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents of the National Heart, Lung, and Blood Institute and the 2013 Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults from the American College of Cardiology and American Heart Association. After imputing missing data and applying NHANES sampling weights, we extrapolated the results to 20.4 million noninstitutionalized young people aged 17 to 21 years living in the United States. ResultsOf the 6338 young people aged 17 to 21 years in the NHANES population, 2.5% (95% CI, 1.8%-3.2%) would qualify for statin treatment under the pediatric guidelines compared with 0.4% (95% CI, 0.1%-0.8%) under the adult guidelines. Participants who met pediatric criteria had lower mean (SD) LDL-C levels (167.3 [3.8] vs 210.0 [7.1] mg/dL) but higher proportions of other cardiovascular risk factors, including hypertension (10.8% vs 8.4%), smoking (55.0% vs 23.9%), and obesity (67.7% vs 18.2%) compared with those who met the adult guidelines. Extrapolating to the US population of individuals aged 17 to 21 years represented by the NHANES sample, 483 500 (95% CI, 482 100-484 800) young people would be eligible for treatment of LDL-C levels if the pediatric guidelines were applied compared with only 78 200 (95% CI, 77 600-78 700) if the adult guidelines were applied. Conclusions and RelevanceApplication of pediatric vs adult guidelines for lipid levels, which consider additional cardiovascular risk factors beyond age and LDL-C concentration, might result in statin treatment for more than 400 000 additional adolescents and young adults.
JAMA Pediatrics – American Medical Association
Published: Jun 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.